SteadyHealth.com - Health Topics Forum Index
  Find a Doctor   Ask Experts      Articles      Encyclopedia   Blogs   Tickers    Search  Register    FAQ    Log in 

May 15, 2006

Myeloproliferative Disorders: Polycythemia vera

by SirGan

SteadyHealth.com - Health Topics Forum Index -> Articles archive

There are six diseases included in the group of myeloproliferative disorders and this group includes chronic:
  • myelogenous leukemia (CML),
  • Polycythemia rubra vera (PRV),
  • chronic idiopathic myelofibrosis,
  • essential thrombocythemia (ET),
  • chronic neutrophilic leukemia, and
  • chronic eosinophilic leukemia.
This group is characterized by production of too many of certain types of blood cells are made in the bone marrow.
Polycythemia vera (PV) is a disease in which body makes too many red blood cells, which makes blood too thick. It could be also described as an abnormal increase in blood cells-primarily red blood cells, resulting from excess production by the bone marrow. The overproduction of red blood cells is most dramatic, but production of white blood cells and platelets is also elevated in most cases. Polycythemia vera is a rare myeloproliferative disorder and it is estimated to occur, in approximately 1 in 100,000 individuals. Polycythemia Vera is primarily affects middle-aged or elderly people. It occurs more frequently in men than women, and rarely in patients under 40 years old. It is not known what causes Polycythemia vera.

Synonyms:
  • Erythremia
  • Osler-Vaquez Disease
  • Primary Polycythemia
  • Splenomegalic Polycythemia
  • Vaquez-Osler Disease
  • Polycythemia Rubra Vera

Bone marrow functions

Bone marrow is the body's blood-forming organ and it contains blood-forming cells called "hematopoeitic precursor or stem cells". These cells have two important functions.
  • self-renewal to maintain a pool of stem cells for future proliferation or growth.
  • ability to mature into adult blood cells that will leave the marrow and enter the circulation.
Normal bone marrow is composed of a family of hematopoeitic clones all reproducing themselves and forming daughter cells that will, in turn, develop into red blood cells, white blood cells and platelets. The normal marrow also balances production of different cell types so they appear in the blood in their proper proportions. When something disturbs this balance- you get all kinds of cells disproportions in blood. Polycythemia vera is one of these disproportions!

Possible causes of Polycythemia vera

Although, the exact cause of Polycythemia vera is still unknown-several evidences are indicating that the etiology could be in unregulated neoplastic proliferation.
The origin of the stem cell transformation remains unknown. Abnormal clone stem cells are present and they interfere with or suppress normal stem cell growth and maturation. Progenitors of the blood cells in these patients display abnormal responses to growth factors, suggesting the presence of a defect in a signaling pathway common to different growth factors.
Although the causative genetic events are yet to be found, two key aspects of the biology can identify it:
  1. clonality - In Polycythemia vera, a single clone population of erythrocytes, granulocytes, B cells, and platelets arises when a hematopoeitic stem cell gains a proliferative advantage over other stem cells.
  2. erythropoietin independence - Erythropoietin independence is the ability of erythroid colonies formed from the Polycythemia vera hematopoeitic stem cell to grow without erythropoietin

Symptoms of Polycythemia vera

In most cases, affected individuals may experience:
  • headaches,
  • weakness,
  • dizziness (vertigo),
  • a ringing noise in the ear (tinnitus).
  • fullness in the left upper abdomen
  • red coloration, especially of the face
  • shortness of breath
  • breathing difficulty when lying down
  • symptoms of phlebitis
In some cases, individuals with Polycythemia vera experience itching (pruritus), especially after a hot bath. Affected individuals often have an abnormally enlarged spleen (splenomegaly) and/or liver (hepatomegaly). In some cases, affected individuals may have associated conditions including:
  • high blood pressure (hypertension),
  • the formation of blood clots (thrombosis),
  • rupturing of and loss of blood (hemorrhaging) from certain blood vessels, and
  • Budd-Chiari syndrome, a rare disorder characterized by obstruction (occlusion) of veins of the liver
  • Vision abnormalities
  • Skin spots, red
  • Bluish skin discoloration
  • Fatigue

Types of Polycythemia vera

Primary polycythemia (also known as polycythemia vera)

     
This type occurs when erythrocytes are produced as a result of a proliferative abnormality of the bone marrow. This doesn’t have to mean that the problem is in the bone marrow because it can also be brought on by tumors in the kidneys since they help to regulate erythrocytes production.
Findings: There may be 8 to 9 million and occasionally 11 million erythrocytes per cubic millimeter of blood. A normal range for adults is 4-5! Hematocrit, complete volume of blood cells, may be as high as 70 to 80%. In addition, the total blood volume sometimes increases to as much as twice normal. The entire vascular system can become filled with blood. The increased numbers of erythrocytes can increase the viscosity of the blood to as much as five times normal. Capillaries can become plugged by the very viscous blood, and the flow of blood through the vessels tends to be extremely sluggish.

Secondary polycythemia

     
Secondary polycythemia is caused by increases in the production of erythropoietin that result in an increased production of erythrocytes.
Findings: There may be 6 to 8 million and occasionally 9 million erythrocytes per cubic millimeter of blood.
Physiologicpolycythemia: A type of secondary polycythemia in which the production of erythropoietin increases appropriately. It occurs in individuals living at high altitudes (4275 to 5200 meters), where oxygen availability is at much smaller concentration than at sea level. Such people may have 6 to 8 million erythrocytes per cubic millimeter of blood.
Other causes of secondary polycythemia include
  • smoking, renal or liver tumors, or
  • heart or lung diseases that result in hypoxia.
  • Endocrine abnormalities, prominently including pheochromocytoma and adrenal adenoma with Cushing's syndrome are also secondary causes.
  •  Athletes and bodybuilders who abuse anabolic steroids or erythropoietin may develop secondary polycythemia.
       

Relative polycythemia

Relative polycythemia is an apparent rise of the erythrocyte level in the blood but the problem isn't in bone marrow or erythropoietin but, underlying cause is reduced blood plasma.  It can be caused by burns, dehydration and stress polycythemia.

Diagnosis of polycythemia

While the diagnosis could be made simply based on blood counts, most doctors- hematologists follow the guidelines of the Polycythemia Vera Study Group and run certain diagnostic tests. If the Study Group findings are present, then a diagnosis can be made with certainty.

Category A

     
  • Total red blood cell mass - In males, greater than or equal to 36 mL/kg; in females, greater than or equal to 32 mL/kg
  • Arterial oxygen saturation greater than or equal to 92%
  • Splenomegaly

Category B

     
  • Thrombocytosis with platelet count greater than 400,000/mL
  • Leukocytosis with a white blood cell count greater than 12,000/mL
  • Increased leukocyte alkaline phosphatase greater than 100 U/L
  • Serum vitamin B-12 concentration greater than 900 pg/mL or binding capacity greater than 2200 pg/mL
The major diagnostic issue related to PV is distinguishing it from other forms of erythrocytosis, which are more common than PV.
The criteria that must be met for a diagnosis of polycythemia vera and the incidence of these abnormalities at diagnosis are a demonstration of increased red cell mass combined with an:
enlarged spleen (splenomegaly) which is presenting 75% of cases or any two other features of pluripotential precursor cell involvement, such as:
  • increased platelet counts (35-50%),
  • neutrophilia (50-80%),
  • increased leukocyte alkaline phosphate activity (80%), or
  • increased vitamin B12 binding protein (67%).

Complications

Main mechanism is that the increased blood volume and increased circulating red cell mass play a key role in the symptoms and complications experienced in cases of uncontrolled polycythemia vera.
Thrombosis and hemorrhage are the major complications.

Thrombosis

     
Thrombosis may be arterial (coronary, cerebral, peripheral vascular) or venous (involving peripheral, hepatic or portal veins). Small vessel insufficiency produces cyanosis (slightly bluish, grayish or dark purple discoloration), pain in fingers and toes, or gangrene of the digits.

Hemorrhage

     
Mild hemorrhagic phenomena such as nosebleeds, bleeding gums and easy bruisability are common. There could be some even more serious problems with bleeding such as:
  • black tarry stool,
  • hemostatsis (stagnation of blood-lack of circulation),
  • menorrhagia (excessive menstrual bleeding) or
  • coughing up blood which can originate from the mouth, larynx, trachea, bronchi in 10% of patients.

Treatment

Because the condition cannot be cured, treatment focuses on treating symptoms and reducing thrombotic complications reducing the erythrocyte levels.

Phlebotomy

     
Bloodletting or phlebotomy is one form of treatment, which often may be combined with other therapies. The purpose of phlebotomy is to reduce the red blood cell mass -that is, the total number of circulating red blood cells, and to do it fairly quickly, at least in the beginning when the hematocrit is high.

Chemotherapy

This form of therapy for polycythemia may be used sparingly, when the rate of bloodlettings required to maintain normal hematocrit is not acceptable.
Other therapies include
  • interferon injections,
  • anagrelide
COMMENTS
Readers posted 0 comments for this article



ARTICLE RATING


[ 0 voters ]

Rate this article:

bad
average
good
very good
excellent

RELATED ARTICLES
SYNDICATE FEED






    Article sources
    • www.wikipedia.com
    • www.acor.org